Phase III trials
China Biotech Phase III Pipeline August 2025: 10 Newly Disclosed Trials
From Aug 1–28, 2025, 10 new Phase III trials launched in China, including YP0322, DZD8586, MRG004A, TQB2868, QLS32015, TQC3721, SHR-A2015, MT1013, FCN-159, and HS-20094, spanning oncology, CNS, respiratory, and metabolic diseases.